[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kia et al., 2019 - Google Patents

Integration of eQTL and Parkinson's disease GWAS data implicates 11 disease genes

Kia et al., 2019

View PDF
Document ID
14989989289492873018
Author
Kia D
Zhang D
Guelfi S
Manzoni C
Hubbard L
United Kingdom Brain Expression Consortium (UKBEC)
International Parkinson’s Disease Genomics Consortium (IPDGC)
Reynolds R
Botía J
Ryten M
Ferrari R
Lewis P
Williams N
Trabzuni D
Hardy J
Wood N
Publication year
Publication venue
BioRxiv

External Links

Snippet

Substantial genome-wide association study (GWAS) work in Parkinson's disease (PD) has led to an increasing number of loci shown reliably and robustly to be associated with the increased risk of the disease. Prioritising causative genes and pathways from these studies …
Continue reading at www.biorxiv.org (PDF) (other versions)

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/18Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Health care, e.g. hospitals; Social work
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Similar Documents

Publication Publication Date Title
Broekema et al. A practical view of fine-mapping and gene prioritization in the post-genome-wide association era
Wray et al. Common disease is more complex than implied by the core gene omnigenic model
Bandres‐Ciga et al. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
Zhou et al. Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals
Unal Gulsuner et al. Mitochondrial serine protease HTRA2 p. G399S in a kindred with essential tremor and Parkinson disease
Gazzellone et al. Uncovering obsessive-compulsive disorder risk genes in a pediatric cohort by high-resolution analysis of copy number variation
Arguello et al. Genetic and cognitive windows into circuit mechanisms of psychiatric disease
Ni et al. The GWAS risk genes for depression may be actively involved in Alzheimer’s disease
Xiao et al. The cAMP responsive element-binding (CREB)-1 gene increases risk of major psychiatric disorders
Xie et al. Serotonin transporter 5‐HTTLPR genotype moderates the effects of childhood adversity on posttraumatic stress disorder risk: A replication study
Wade et al. Genetic variants associated with disordered eating
Maestrini et al. Identifying autism susceptibility genes
Nalls et al. Parkinson’s disease genetics: identifying novel risk loci, providing causal insights and improving estimates of heritable risk
Shinozaki et al. New developments in the genetics of bipolar disorder
Acosta et al. ADGRL 3 (LPHN 3) variants are associated with a refined phenotype of ADHD in the MTA study
Wu et al. RNA sequencing in post‐mortem human brains of neuropsychiatric disorders
CN106170561A (en) The diagnosis of autism spectrum disorder and prediction
Subaran et al. Novel variants in ZNF34 and other brain‐expressed transcription factors are shared among early‐onset MDD relatives
Alazami et al. NECAP1 loss of function leads to a severe infantile epileptic encephalopathy
Amor Investigating the child with intellectual disability
Kia et al. Integration of eQTL and Parkinson’s disease GWAS data implicates 11 disease genes
Han et al. Identification of key long non-coding RNAs in the pathology of Alzheimer’s disease and their functions based on genome-wide associations study, microarray, and RNA-seq data
Stepanov et al. Replicative study of susceptibility to childhood-onset schizophrenia in Kazakhs
Arenella et al. Autism spectrum disorder and brain volume link through a set of mTOR‐related genes
Houle et al. Teneurin transmembrane protein 4 is not a cause for essential tremor in a Canadian population